PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $88.59 | -0.6% | +3.6% | +12.2% | +33.4% | +306.6% | +217.4% | +34.1% | |
| TTM Revenue | $669.50M | +7.6% | – | +7.6% | – | +16.9% | +161.3% | +522.0% | |
| TTM EPS | -$2.24 | -4.4% | – | -4.4% | – | -77.5% | -31.3% | -83.8% | |
| 26.88 | -0.6% | +3.9% | +48.3% | +67.5% | +366.7% | +228.2% | +70.6% | ||
| 18.69 | -0.6% | +3.9% | +4.5% | +123.6% | +256.0% | +60.1% | -70.8% | ||
| $12.29B | -0.6% | +3.9% | +14.7% | +38.2% | +335.3% | +369.0% | +92.2% | ||
| -61.25 | +0.6% | -4.0% | -12.3% | -324.3% | -85.3% | -295.4% | -21.5% | ||
| Market Cap | $13B | -0.6% | +3.9% | +12.5% | +37.2% | +315.7% | +318.6% | +81.8% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | 42.32 | N/A | |
| 1Y | 47.46 | N/A | |
| 3Y | 47.46 | N/A | |
| 5Y | 47.46 | N/A | |
| All | 424.45 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | 35.76 | N/A | |
| 1Y | 35.76 | N/A | |
| 3Y | 35.76 | N/A | |
| 5Y | 35.76 | N/A | |
| All | 35.76 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 43.16 | -63.1% |
| Date | Value | Change |
|---|---|---|
| 117.09 | - |
FAQ
- What is ARWR PE ratio 1-year high?
- ARWR PE ratio reached a 1-year high of 47.46 on February 2, 2026
- What is ARWR PE ratio 1-year low?
- ARWR PE ratio reached a 1-year low of 35.76 on March 12, 2026
Formula
Data Sources & References
- ARWR Official Website arrowheadpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
- ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
- ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr
